1-9 of 9
Irwindeep Sandhu, MDFRCPC
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall and Progression Free Survival from the Mcrn-003/Myx.1 Trial: A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma

Christopher P Venner, MD, Richard Leblanc, MDFRCPC, Irwindeep Sandhu, MDFRCPC, Darrell J White, MD, Andrew Belch, MD, Donna E Reece, MD, Christine I Chen, MD, Sean Dolan, MD, Marc Lalancette, MD FRCP, Martha L Louzada, MDMSc, Andrea Kew, MDFRCP(C), Arleigh McCurdy, MD, Tony Reiman, MD, Max Sherry, Gail T. McDonald, Bethany Elaine Monteith, MD, Engin Gul, BS, MBA, Bingshu E. Chen, Annette E. Hay
Journal: Blood
Blood (2019) 134 (Supplement_1): 1871.
https://doi.org/10.1182/blood-2019-122637
Published: 2019
Journal Articles

MCRN ¯ 003/MYX · 1: A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma after 1-3 Prior Therapies

Christopher P. Venner, MD FRCPC, Richard Leblanc, MDFRCPC, Irwindeep Sandhu, MDFRCPC, Darrell J. White, MD, Andrew R Belch, MD, Donna E Reece, MD, Christine I Chen, MD, Sean Dolan, MD, Andrea Kew, MDFRCP(C), Marc Lalancette, MD FRCP, Martha L Louzada, MD, Arleigh McCurdy, MD BSc, Gail T. McDonald, Tony Reiman, MD, Laura Rodriguez, Lois E. Shepherd, Engin Gul, BSc, Bingshu E. Chen, Annette E Hay
Journal: Blood
Blood (2018) 132 (Supplement 1): 1984.
https://doi.org/10.1182/blood-2018-99-117824
Published: 2018
Journal Articles

Updated Results from the Phase 2 Centaurus Study of Daratumumab (DARA) Monotherapy in Patients with Intermediate-Risk or High-Risk Smoldering Multiple Myeloma (SMM)

Ola Landgren, MD PhD, Michele Cavo, MD, Ajai Chari, MD, Yael C Cohen, MD, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Peter M. Voorhees, MD, Jane Estell, FRACP, Irwindeep Sandhu, MDFRCPC, Matthew Jenner, Catherine Williams, Niels WCJ van de Donk, MD PhD, Meral Beksac, MD, Hartmut Goldschmidt, MD, Philippe Moreau, Steven Kuppens, Rajesh Bandekar, Tobias Neff, Annelore Cortoos, MD, Pamela L Clemens, PhD, Ming Qi, Homer Adams, III, PhD, Craig C Hofmeister, MDMPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 1994.
https://doi.org/10.1182/blood-2018-99-113467
Published: 2018
Journal Articles

Detection of Minimal Residual Disease in Autograft Is Prognostic of Survival Following Stem Cell Transplant in Multiple Myeloma

Michael P. Chu, MD, Eva Baigorri, Jitra Kriangkum, PhD, Joanne D. Hewitt, NP, PhD, Andrew Belch, Christopher P. Venner, Irwindeep Sandhu, MDFRCPC, Linda M. Pilarski, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1928.
https://doi.org/10.1182/blood.V130.Suppl_1.1928.1928
Published: 2017
Journal Articles

Utility of Leukemic Stem Cells Markers in Determining Minimal Residual Disease in Patients with AML

Mohammad Refaei, MD BSc, MSc, Artur J Szkotak, MD PhD, Irwindeep Sandhu, MDFRCPC, Joseph M. Brandwein, MD FRCPC, Lalit Saini, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3941.
https://doi.org/10.1182/blood.V130.Suppl_1.3941.3941
Published: 2017
Journal Articles

Two Cycles of Consolidation Chemotherapy Are Associated with Similar Clinical Outcomes to Three Cycles in AML Patients with Favorable Risk Cytogenetics

Daniel Sawler, MD BSc, David Sanford, MD, Joseph M. Brandwein, MD FRCPC, Irwindeep Sandhu, MDFRCPC, Donna Hogge, Lalit Saini, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 464.
https://doi.org/10.1182/blood.V130.Suppl_1.464.464
Published: 2017
Journal Articles

A Strategy of Day 14 Bone Marrows and Early Intervention Is Associated with Similar Outcomes Compared to a Strategy of No Day 14 Bone Marrows and Delayed Intervention in Patients with Acute Myeloid Leukemia

Osman Radhwi, MD, Joseph M. Brandwein, MD FRCPC, Irwindeep Sandhu, MDFRCPC, Lalit Saini, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2584.
https://doi.org/10.1182/blood.V130.Suppl_1.2584.2584
Published: 2017
Journal Articles

The Survival Impact of Lenalidomide Maintenance Chemotherapy in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplant and Bortezomib-Based Induction: An Analysis of Real World Data

Hannah Cherniawsky, BSc, MD, Irwindeep Sandhu, MDFRCPC, Michael P. Chu, MD, Joanne D. Hewitt, NP, PhD, Ismail Ismail, Andrew Belch, Linda M. Pilarski, PhD, Tatiana Nikitina, PhD, Christopher P. Venner, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3132.
https://doi.org/10.1182/blood.V130.Suppl_1.3132.3132
Published: 2017
Journal Articles

The Evolving Impact on Survival Outcomes in Multiple Myeloma with Greater Access to Novel Treatment Regimens: Experience in a Real-World Cohort

Zack M. Breckenridge, BSc, Victor Jimenez-Zepeda, MD, Nizar J. Bahlis, MD, Paola Neri, MD, Irwindeep Sandhu, MDFRCPC, Michael P. Chu, MD, Ismail Ismail, Jason Tay, MD FRCPC, Peter Duggan, MD FRCPC, Andrew Belch, Joanne D. Hewitt, NP, PhD, Linda M. Pilarski, PhD, Tatiana Nikitina, Christopher P. Venner
Journal: Blood
Blood (2017) 130 (Supplement 1): 1859.
https://doi.org/10.1182/blood.V130.Suppl_1.1859.1859
Published: 2017